<!DOCTYPE html>
<html>
<head>
    <title>BREAKING: Federal Register: Atopic Dermatitis: Timing of Pediatric Studies During Development of Systemic Drugs; Draft Guidance for Industry; Availability</title>
    <meta charset="UTF-8">
    <style>
        body { font-family: Georgia, serif; max-width: 800px; margin: 0 auto; padding: 20px; }
        h1 { border-bottom: 2px solid #333; }
        .breaking { background: #fff3cd; border-left: 4px solid #dc3545; padding: 15px; }
        .source { background: #f8f9fa; padding: 10px; margin-top: 20px; font-size: 0.9em; }
        .timestamp { color: #666; }
    </style>
</head>
<body>
    <h1>BREAKING: Federal Register: Atopic Dermatitis: Timing of Pediatric Studies During Development of Systemic Drugs; Draft Guidance for Industry; Availability</h1>
    <p class="timestamp">Published: 2018-04-09 | Source: Federal Register</p>
    <div class="breaking">
        <p><strong>The Food and Drug Administration (FDA or Agency) is announcing the availability of a draft guidance for industry entitled "Atopic Dermatitis: Timing of Pediatric Studies During Development of Systemic Drugs." This draft guidance addresses FDA's current thinking about the relevant age groups to study and how early in the drug development pediatric patients should be incorporated during development of systemic drugs for atopic dermatitis (AD).</strong></p>
    </div>
    <h2>Document Details</h2>
    <p><strong>Document Type:</strong> Notice</p>
    <p><strong>Agency:</strong> Health and Human Services Department, Food and Drug Administration</p>
    <p><strong>Document Number:</strong> 2018-07150</p>
    <p><strong>Publication Date:</strong> 2018-04-09</p>
    <h2>Official Source</h2>
    <p>Read the full document at: <a href="https://www.federalregister.gov/documents/2018/04/09/2018-07150/atopic-dermatitis-timing-of-pediatric-studies-during-development-of-systemic-drugs-draft-guidance">https://www.federalregister.gov/documents/2018/04/09/2018-07150/atopic-dermatitis-timing-of-pediatric-studies-during-development-of-systemic-drugs-draft-guidance</a></p>
    <div class="source"><strong>Source:</strong> Federal Register - 2018-07150</div>
    <p><a href="index.html">Back to Breaking News Wire</a></p>
</body>
</html>
